NOVAVAX INC
Develops and commercializes nanoparticle vaccines for serious infectious diseases.
NVAX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6700024010
- LEI:
- Country:
- United States of America
- Address:
- 700 QUINCE ORCHARD ROAD, 20878 GAITHERSBURG
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Novavax Inc. is a biotechnology company that discovers, develops, and commercializes vaccines to prevent serious infectious diseases. The company's core technology is a proprietary recombinant nanoparticle platform used to create vaccine candidates, complemented by its Matrix-M™ adjuvant, which enhances the immune response. A key commercial product is Nuvaxovid™, a protein-based, non-mRNA COVID-19 vaccine. Novavax focuses on addressing significant global health challenges through its research and development pipeline and strategic partnerships to maximize the impact of its assets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NOVAVAX INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NOVAVAX INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NOVAVAX INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
